These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 489198)

  • 1. Comparison of isoniazid phenotyping of black and white patients with emphasis on South African blacks.
    Eidus L; Glatthaar E; Hodgkin MM; Nel EE; Kleeberg HH
    Int J Clin Pharmacol Biopharm; 1979 Jul; 17(7):311-6. PubMed ID: 489198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotyping of South African black tuberculosis patients for inactivation of isoniazid.
    Eidus L; Glatthaar E; Hodgkin MM; Nel EE; Kleeberg HH
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):243-56. PubMed ID: 461951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoniazid phenotyping of black as well as white patients.
    Hodgkin MM; Eidus L; Bailey WC
    Can J Physiol Pharmacol; 1979 Jul; 57(7):760-3. PubMed ID: 487286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the acetylator phenotype using matrix isoniazid.
    Ellard GA; Gammon PT; Titinen H
    Tubercle; 1975 Sep; 56(3):203-9. PubMed ID: 1216339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoniazid acetylator status of Black South African tuberculosis patients.
    Bach PH; Higgins-Opitz SB; Bima B; Leary WP
    S Afr Med J; 1976 Jul; 50(29):1132-4. PubMed ID: 959925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of isoniazid by Canadian Eskimos and Indians.
    Jeanes CW; Schaefer O; Eidus L
    Can Med Assoc J; 1972 Feb; 106(4):331-5. PubMed ID: 5061127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoniazid disposition, comparison of isoniazid phenotyping methods in and acetylator distribution of Japanese patients with idiopathic systemic lupus erythematosus and control subjects.
    Horai Y; Ishizaki T; Sasaki T; Koya G; Matsuyama K; Iguchi S
    Br J Clin Pharmacol; 1982 Mar; 13(3):361-74. PubMed ID: 7059436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of various isoniazid slow releasing matrix preparations for intermittent chemotherapy of tuberculosis.
    Hodgkin MM; Eidus L; Hershfield ES
    Res Commun Chem Pathol Pharmacol; 1979 May; 24(2):349-65. PubMed ID: 461989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative blood levels and metabolism of INH and an INH-matrix preparation in fast and slow inactivators.
    Jeanes CW; Schaefer O; Eidus L
    Can Med Assoc J; 1973 Sep; 109(6):483-7. PubMed ID: 4742916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the acetylator phenotype in Moroccan tuberculosis patients using isoniazid as metabolic probe.
    Aït Moussa L; Khassouani CE; Hüe B; Jana M; Bégaud B; Soulaymani R
    Int J Clin Pharmacol Ther; 2002 Dec; 40(12):548-53. PubMed ID: 12503812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid.
    Donald PR; Parkin DP; Seifart HI; Schaaf HS; van Helden PD; Werely CJ; Sirgel FA; Venter A; Maritz JS
    Eur J Clin Pharmacol; 2007 Jul; 63(7):633-9. PubMed ID: 17505821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcoidosis in South Africa. A comparative study in Whites, Blacks and Coloureds.
    Benatar SR
    S Afr Med J; 1977 Oct; 52(15):602-6. PubMed ID: 918803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Isoniazid metabolism in black patients.
    Bach PH; Higgins-Opitz SB; Leary WP
    S Afr Med J; 1975 Nov; 49(47):1949. PubMed ID: 1198224
    [No Abstract]   [Full Text] [Related]  

  • 14. A new isoniazid preparation designed for moderately fast and "fast" metabolizers of the drug.
    Eidus L; Hodgkin MM
    Arzneimittelforschung; 1975 Jul; 25(7):1077-80. PubMed ID: 1101901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoniazid acetylation phenotyping in Saudi Arabs.
    Matar KM; Mayet AY; Ayoola EA; Bawazir SA; Al-Faleh FZ; Al-Wazzan A
    J Clin Pharm Ther; 2004 Oct; 29(5):443-7. PubMed ID: 15482388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine test for phenotyping isoniazid inactivators.
    Eidus L; Harnanansingh AM; Jessamine AG
    Am Rev Respir Dis; 1971 Oct; 104(4):587-91. PubMed ID: 5094058
    [No Abstract]   [Full Text] [Related]  

  • 17. A single sample saliva test to determine acetylator phenotype.
    Hutchings AD; Routledge PA
    Br J Clin Pharmacol; 1996 Nov; 42(5):635-7. PubMed ID: 8951197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of cross-sectional geometry of the proximal femur in white and black women from Detroit and Johannesburg.
    Nelson DA; Pettifor JM; Barondess DA; Cody DD; Uusi-Rasi K; Beck TJ
    J Bone Miner Res; 2004 Apr; 19(4):560-5. PubMed ID: 15005842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saliva and plasma concentrations of isoniazid and acetylisoniazid in man.
    Hutchings AD; Monie RD; Spragg BP; Routledge PA
    Br J Clin Pharmacol; 1988 May; 25(5):585-9. PubMed ID: 3408638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone density in black and white South African women: contribution of ethnicity, body weight and lifestyle.
    Conradie M; Conradie MM; Kidd M; Hough S
    Arch Osteoporos; 2014; 9():193. PubMed ID: 25190256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.